Doctor profile · Federal record
Dr. Kristine Rinn, MD
Medical Oncology Physician (CMS: Hematology/Oncology) · Spokane Valley, WA
- NPI 1174607899
- Accepts Medicare
- 34 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1204 N Vercler RD
Spokane Valley, WA 992161020
(509) 228-1000
fax (509) 252-9300 - Additional location
-
1221 Madison St
Seattle, WA 981043588
(206) 386-2323
fax (206) 386-2729
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- April 23, 2021
- Year of graduation
- 1992 — 34 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Washington #MD00032076
- Medicaid (2)
- WA #1174607899 · WA #8251738
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174607899. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
81,452
Distinct HCPCS
10
Medicare allowed
$1,081,098
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 20,900 | 14 | $3 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 15,000 | 14 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 10,002 | 14 | $54 | |
J9267 |
Injection, paclitaxel, 1 mg | 8,045 | 12 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 7,860 | 43 | $23 | |
J0185 |
Injection, aprepitant, 1 mg | 6,630 | 23 | $2 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,934 | 74 | $0 | |
J9395 |
Injection, fulvestrant, 25 mg | 2,000 | 20 | $10 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 1,930 | 38 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 700 | 30 | $1 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 1,851. This provider delivers 44× the peer median.Open Payments
Industry payments received
All-time total
$804
Transactions
24
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $247.66 | |
| Tempus AI, Inc | 2 | $153.44 | |
| Gilead Sciences, Inc. | 2 | $46.68 | |
| Mirati Therapeutics, Inc. | 2 | $42.50 | |
| Blueprint Medicines Corporation | 2 | $41.27 | |
| PFIZER INC. | 3 | $40.83 | |
| Octapharma USA, Inc. | 1 | $32.17 | |
| AstraZeneca Pharmaceuticals LP | 1 | $25.95 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $25.50 | |
| Myriad Genetic Laboratories, Inc. | 1 | $23.62 | |
| Lilly USA, LLC | 1 | $23.18 | |
| Fennec Pharmaceuticals, Inc. | 1 | $19.95 | |
| Celgene Corporation | 1 | $19.91 | |
| Dendreon Pharmaceuticals LLC | 1 | $19.87 | |
| Acrotech Biopharma Inc. | 1 | $14.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
904
Patients
256
Total drug cost
$638,434
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 237 | 75 | $7,584 |
| Anastrozole | Generic | 170 | 57 | $5,516 |
| Tamoxifen Citrate | Generic | 84 | 35 | $3,434 |
| Gabapentin | Generic | 66 | 24 | $2,488 |
| Exemestane | Generic | 46 | 14 | $5,653 |
| Ibrance (Palbociclib) | Brand | 42 | 0 | $610,439 |
| Famotidine | Generic | 41 | 13 | $375 |
| Ondansetron Odt (Ondansetron) | Brand | 37 | 23 | $669 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | Brand | 32 | 0 | $404 |
| Trazodone Hcl | Generic | 30 | 0 | $203 |
Frequently asked questions
What is Dr. Kristine Rinn's medical specialty?
Dr. Kristine Rinn practices Medical Oncology Physician in Spokane Valley, WA.
Where does Dr. Kristine Rinn practice?
Dr. Kristine Rinn practices at 1204 N Vercler RD, Spokane Valley, WA 992161020. Office phone: 5092281000.
What is Dr. Kristine Rinn's NPI?
Dr. Kristine Rinn's National Provider Identifier (NPI) is 1174607899, issued by NPPES.
Does Dr. Kristine Rinn accept Medicare assignment?
Yes. Dr. Kristine Rinn accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kristine Rinn commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.